Protox Therapeutics Inc. (PRX.V) Announces Closing of Additional CDN $8.3 Million Investment by Warburg, Pincus Ventures, L.P.
12/28/2011 9:59:07 AM
More...
|
Protox Therapeutics Inc. (PRX.V) Appoints Richard Yocum as Chief Medical Officer
12/12/2011 9:03:01 AM
More...
|
Protox Therapeutics Inc. (PRX.V) Announces Move to San Diego and Senior Management Transition
4/18/2011 10:06:46 AM
More...
|
Protox Therapeutics Inc. (PRX.V) Appoints Two New Directors
2/22/2011 10:11:59 AM
More...
|
Warburg, Pincus Ventures, L.P. to Invest $35 Million in Protox Therapeutics Inc. (PRX.V)
9/30/2010 7:32:50 AM
More...
|
Protox Therapeutics Inc. (PRX.V) Six-Month Prostate Drug Data Muted
6/2/2010 8:08:46 AM
More...
|
Protox Therapeutics Inc. (PRX.V) Signs $75 Million License Agreement with Kissei Pharmaceutical Co., Ltd. for Commercialization of PRX302 in Japan for BPH and Prostate Disease
4/29/2010 2:58:46 PM
More...
|
Protox Therapeutics Inc. (PRX.V) Reports 2009 Financial Results And Achievements
3/31/2010 11:41:17 AM
More...
|
Protox Therapeutics Inc. (PRX.V) Reports Positive Phase2 Trial Results For Urological Drug
1/13/2010 9:52:41 AM
More...
|
Protox Therapeutics Inc. (PRX.V) Reports 2009 Third Quarter Results
11/16/2009 12:09:36 PM
More...
|
|